Literature DB >> 8106701

Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging.

N Fujita1, A F Chazouilleres, J J Hartiala, M O'Sullivan, P Heidenreich, J D Kaplan, H Sakuma, E Foster, G R Caputo, C B Higgins.   

Abstract

OBJECTIVES: The feasibility of velocity-encoded cine nuclear magnetic resonance (NMR) imaging to measure regurgitant volume and regurgitant fraction in patients with mitral regurgitation was evaluated.
BACKGROUND: Velocity-encoded cine NMR imaging has been reported to provide accurate measurement of the volume of blood flow in the ascending aorta and through the mitral annulus. Therefore, we hypothesized that the difference between mitral inflow and aortic systolic flow provides the regurgitant volume in the setting of mitral regurgitation.
METHODS: Using velocity-encoded cine NMR imaging at a magnet field strength of 1.5 T and color Doppler echocardiography, 19 patients with isolated mitral regurgitation and 10 normal subjects were studied. Velocity-encoded cine NMR images were acquired in the short-axis plane of the ascending aorta and from the short-axis plane of the left ventricle at the level of the mitral annulus. Two independent observers measured the ascending aortic flow volume and left ventricular inflow volume to calculate the regurgitant volume as the difference between left ventricular inflow volume and aortic flow volume, and the regurgitant fraction was calculated. Using accepted criteria of color flow Doppler imaging and spectral analysis, the severity of mitral regurgitation was qualitatively graded as mild, moderate or severe and compared with regurgitant volume and regurgitant fraction, as determined by velocity-encoded cine NMR imaging.
RESULTS: In normal subjects the regurgitant volume was -6 +/- 345 ml/min (mean +/- SD). In patients with mild, moderate and severe mitral regurgitation, the regurgitant volume was 156 +/- 203, 1,384 +/- 437 and 4,763 +/- 2,449 ml/min, respectively. In normal subjects the regurgitant fraction was 0.7 +/- 6.1%. In patients with mild, moderate and severe mitral regurgitation, the regurgitant fraction was 3.1 +/- 3.4%, 24.5 +/- 8.9% and 48.6 +/- 7.6%, respectively. The regurgitant fraction correlated well with the echocardiographic severity of mitral regurgitation (r = 0.87). Interobserver reproducibilities for regurgitant volume and regurgitant fraction were excellent (r = 0.99, SEE = 238 ml; r = 0.98, SEE = 4.1%, respectively).
CONCLUSIONS: These findings suggest that velocity-encoded NMR imaging can be used to estimate regurgitant volume and regurgitant fraction in patients with mitral regurgitation and can discriminate patients with moderate or severe mitral regurgitation from normal subjects and patients with mild regurgitation. It may be useful for monitoring the effect of therapy intended to reduce the severity of mitral regurgitation.

Entities:  

Mesh:

Year:  1994        PMID: 8106701     DOI: 10.1016/0735-1097(94)90642-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  36 in total

Review 1.  Magnetic resonance imaging in valvular heart disease.

Authors:  M Schmidt; J Crnac; B Dederichs; P Theissen; H Schicha; U Sechtem
Journal:  Int J Card Imaging       Date:  1997-06

2.  MR of acquired heart disease: valvular heart disease.

Authors:  G P Reddy
Journal:  Int J Cardiovasc Imaging       Date:  2001-12       Impact factor: 2.357

3.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 4.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

Review 5.  Cardiac imaging in valvular heart disease.

Authors:  W S Choo; R P Steeds
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

6.  Mitral regurgitation quantification by cardiovascular magnetic resonance: a comparison of indirect quantification methods.

Authors:  Christian L Polte; Odd Bech-Hanssen; Åse A Johnsson; Sinsia A Gao; Kerstin M Lagerstrand
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-23       Impact factor: 2.357

Review 7.  Valvular heart disease: what does cardiovascular MRI add?

Authors:  Pier Giorgio Masci; Steven Dymarkowski; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-08-29       Impact factor: 5.315

8.  Cardiac MRI in the management of congenital heart disease in children, adolescents, and young adults.

Authors:  Pamela K Woodard; Sanjeev Bhalla; Cylen Javidan-Nejad; Andrew Bierhals; Fernando R Gutierrez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

9.  Quantification of left ventricular remodeling in response to isolated aortic or mitral regurgitation.

Authors:  Seth Uretsky; Azhar Supariwala; Puspalatha Nidadovolu; Surinder S Khokhar; Cindy Comeau; Oleg Shubayev; Francesca Campanile; Steven D Wolff
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-24       Impact factor: 5.364

10.  Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements.

Authors:  Peter D Gatehouse; Marijn P Rolf; Martin J Graves; Mark Bm Hofman; John Totman; Beat Werner; Rebecca A Quest; Yingmin Liu; Jochen von Spiczak; Matthias Dieringer; David N Firmin; Albert van Rossum; Massimo Lombardi; Juerg Schwitter; Jeanette Schulz-Menger; Philip J Kilner
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-14       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.